peptide pt141 PT-141 (Bremelanotide) PT-141 (10mg) – True Lab

Research Use Limitation Used solely for in vitro experiments Not permitted for clinical trials involving humans Not permitted for human or veterinary administration Not permitted for investigational human use Independently analysed by Liquilabs s.r.o

Antimicrobial potential of leuconostoc species against E

RMSD values calculated between rTs24GST and each structure individually, as well as for all structures combined

Serious but less common risks may include: Stevens-Johnson syndrome or toxic epidermal necrolysis (rare, reported with injectable use), severe allergic reactions, thyroid dysfunction, kidney dysfunction, and infection at injection/IV sites

Free from harmful additives, it is suitable for sensitive skin types

Most vitamin IV therapies qualify for FSA or HSA reimbursement